Healius Ltd (ASX: HLS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Healius Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Healius Ltd (ASX: HLS)
Latest News
⏸️ Investing
PRICE CRASH: Is there any value in Capitol Health Ltd shares?
⏸️ Lessons From Investing Greats
3 great quotes to make you a better investor
⏸️ Investing
Why these 4 ASX shares crashed on the market today
⏸️ Investing
Can Primary Health Care Limited's share price rebound from its 10-year low?
⏸️ Investing
CRASH: Why the Primary Health Care Limited share price was smashed today
⏸️ Investing
3 shares trading at 52-week lows: Is it time to pick up a bargain?
⏸️ Investing
Government to rip out $639 million from pathology and diagnostic imaging
⏸️ Investing
Is it time to buy shares in Santos Ltd, Healthscope Ltd, and Primary Health Care Limited?
⏸️ Investing
Should you buy Capitol Health Ltd at this share price?
⏸️ Investing
Why you should avoid the top 20 most shorted shares on the ASX
⏸️ Investing
Why the Monash IVF Group Ltd share price soared today
⏸️ Investing
4 investment themes to send your share portfolio higher
Frequently Asked Questions
-
Yes, Healius has historically paid two fully franked shareholder dividends a year.
-
Healius has generally paid its shareholder dividends in March/April and September/October.
-
Healius Ltd listed on the ASX on 3 July 1998.
HLS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Healius Ltd
Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.
The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres.
The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics.
